Updated: August 2026
Published by Physician Growth Partners (PGP)
The dental M&A market continues its steady flow of M&A activity as private equity-backed groups continue with buy-and-build strategies. In addition to a solid pipeline and proven ability to integrate, organic growth has emerged as a critical attribute ahead of upcoming recapitalizations.
The U.S. dental practice sector remains a cornerstone of the healthcare services market, with the broader domestic industry generating approximately $196 billion in revenue in 2026. Long-term growth is expected to compound at approximately 1.2% annually, sustained by steady clinical utilization.2
Currently, the market is defined by a supply-demand dislocation. Most DSOs planned to increase their acquisition activity in 2026; however, the inventory of premium practices remains severely constrained. This immediate capital pressure contrasts with long-term demographic data showing that 34% of all active U.S. dentists are aged 55 or older, with several states seeing this cohort exceed 40%.1 For the independent operator, this dual reality means that the present moment represents an opportunistic time to explore a sale. Dental Service Organizations (DSOs) and their institutional sponsors are competing aggressively for high-performing practices to execute add-on strategies and secure regional density as DSOs are willing to pay premiums for practices with established clinical infrastructure. However, they are applying a high level of scrutiny to operational readiness and provider transition risk to protect their investments.
At the same time, a significant portion of the provider market is approaching a generational transition, which will fundamentally alter seller leverage over the next several years. The structural bottleneck between aggressive DSO capital deployment and a limited supply of premium practices means that well-managed, associate-driven dental groups with quality hygiene programs and proven organic growth success can achieve strong valuation outcomes. This market intelligence update is designed to unpack these competitive dynamics, helping independent owner-operators of dental practices and groups understand their strategic options ahead of a potential future transaction.
Valuations in the general dental sector continue to hold steady, anchored by premium regional platform transactions. Several notable transactions occurred over the last 6+ months, including:
These transactions continue to reinforce and support strong market valuations. Large, multi-location operators generating more than $10 million of EBITDA, with established management teams, scalable infrastructure, and a proven ability to drive growth through new location openings, same-store sales growth, and acquisitions, are highly attractive platform opportunities. These businesses can command premium valuations exceeding 11.0x EBITDA.
Practices generating between $5 million and $10 million of EBITDA can also represent highly attractive platform opportunities, particularly when supported by strong management teams, established infrastructure, and a demonstrated track record of organic and acquisition-driven growth. Valuations for businesses in this segment can often range from approximately 9.0x to 11.0x EBITDA.
Dental practices generating between $3 million and $5 million of EBITDA may trade in the range of approximately 8.0x to 10.0x EBITDA, depending on factors such as management depth, infrastructure, operational sophistication, growth profile, and geography.
Smaller practices generating $1 million to $3 million of EBITDA will typically transact at lower valuation multiples, generally in the range of 6.0x to 8.0x EBITDA. And practices below this size will often be valued at approximately 3.0x to 5.0x EBITDA or 0.8x to 1.5x revenue. However, with the right preparation and planning, smaller practices can achieve outsized returns in a well-run and competitive process.
While market sentiment remains favorable for top-tier groups, macro-level friction has introduced a period of measured stabilization. Mergermarket data reveals that North American DSO transaction volume nearly halved between 2023 and 2025, dropping from 126 deals to 67 deals, as private equity sponsors faced elevated borrowing costs and grew more cautious.3 Rather than indicating sector weakness, this dislocation highlights a widening spread between premium and mid-tier assets. Buyers are walking away from over-leveraged platforms or highly owner-dependent practices, redirecting their capital toward high-quality, independent businesses with clean accounting, provider runway, and sustainable metrics.
Key valuation drivers:
| Operating Model | Key Valuation Driver |
|---|---|
| Multi-Site Regional Density | Multi-site platform with strong, consistent regional brand density leading with clinical excellence |
| Sub-Specialty Integration | In-house specialty offering including the following: Dental Implants & Full-Arch Restorations Oral Surgery & Extractions Endodontics / Root Canals Orthodontics / Clear Aligners Periodontics Cosmetic & Restorative Dentistry Hygiene & Preventive Care Crowns, Bridges & Prosthodontics |
| Strong Team and Infrastructure | Centralized billing / RCM with a strong management teamsupported by key department leaders |
| Provider Diversification | Diversified provider base with revenue distributed across multiple providers, minimizing reliance on any single dentist |
| Proven Growth Model | Demonstrated ability to drive growth through same-store sales, new clinic openings, and the successful acquisition and integration of additional practices |
The dental services buyer universe consists of several distinct acquirers:
| Date | Platform | Target | Commentary |
|---|---|---|---|
| Sep 2025 | Pearl Street Dental Partners | Best Dental | Continued Pearl Street’s expansion in TX; increased affiliations to ~50 practices and ~100 dentists in TX and OK. |
| Sep 2025 | MB2 Dental | The Smile Lodge | 3-location pediatric dental practice partnership; platform milestone of 800+ practices for MB2 and represents its largest transaction to date. |
| Sep 2025 | Heartland Dental | Smile Design Dentistry | 60 supported general and specialty practices across Central Florida and Tampa. |
| Dec 2025 | Public Market Listing | Park Dental Partners (NASDAQ: PARK) | Raised ~$20 million from IPO; multi-state affiliated dental network with over 200 dentists and 85 practices across MN and western WI. |
| Jan 2026 | Park Dental Partners | Ironwood Dental, Sunlight Dental, Weddell Dental | New state expansion into AZ with Sunlight Dental (Phoenix) and Ironwood Dental (Tucson), as well as continued expansion with its 47th practice in the Twin Cities area with Weddell Dental. |
| Jan 2026 | The Sonrisa Group | Pine Forest | Acquired Pine Forest (Pensacola) to expand network in FL; plans additional states, including NY and AL. |
| Jan 2026 | GTCR | Dentalcorp Holdings (TSX: DNTL) | GTCR, a leading private equity firm, completed its take-private acquisition of Dentalcorp for C$3.3 billion enterprise value; Dentalcorp is Canada’s largest network of dental practices (~600). |
| Feb 2026 | Innovate 32 | Trivette Osborne & Associates | Multi-generation practice in TN, with 60+ years of history, joins fast-growing Innovate 32 network with locations throughout the South and Mid-Atlantic. |
| Mar 2026 | Straine Dental Management | 4405 Dental Studio | Ongoing strategic momentum for SDM with its 6th practice in TX and 56th overall practice. |
| Mar 2026 | The Smilist | Arlington Dental Team | New state expansion into VA, representing The Smilist’s 8th state in the Northeast. |
| May 2026 | Heartland Dental | Western NY (NY), Clear Skies (FL), Lee’s Summit (MO) | Expanded network in May across key U.S. markets and affiliated with 3 offices in NY, FL, MO. |
| May 2026 | Apex Dental Partners | 5 Dental Practices | 5 practices in Colorado; expand Apex’s presence to 12 locations in CO and 65 practices across 8 states. |
| May 2026 | Smile Partners USA | MFD Dental | Smile Partners expansion into MA (seventh market); MFD comprised of 6 unique practices. |
| May 2026 | MB2 Dental | 8 New Practices | Added 8 new practices across five states, increasing 2026 new practice count to 30+. |
| Jun 2026 | Thurston Group / SGA Dental Partners | SGA Dental, Gen4 Dental, Modis Dental | Thurston Group, a private equity firm, united SGA, Gen4, and Modis into a single national group with 250+ locations across 25+ states and 500+ dentists. |
| Jun 2026 | Innovate 32 | Viridian Dental Partners | 5 dental practices and 8 doctors added to expand presence across Middle Tennessee. |
| Jul 2026 | Dentalcorp | Northstar Dental Partners | Acquisition represented Dentalcorp’s (Toronto-based) entry into the U.S. market with Northstar’s 21 practices located across Florida. |
| Jul 2026 | Guardian Dentistry Partners | Select Dental Management | Majority acquisition of Select’s 38 locations across eight states and D.C.; expands Guardian’s footprint in the Mid-Atlantic and Northeast. |
| Jul 2026 | Rising Tide Dental Partners | 6 New Practices | Rising Tide, a leading dentist-owned DPO, integrated six new practices across six states. |
| Aug 2026 | Park Dental Partners | Village Family Dental | Multi-specialty dental group with 12 locations and 48 dentists across southeastern NC in a deal worth up to $46 million. |
PGP is an active advisor in the Dental sector and has represented multiple independent dental groups in transactions with private equity and strategic buyers. A few recent notable PGP dental transactions include:
PGP’s firsthand experience believes that it is a great time to evaluate a potential transaction given the following factors:
Scarcity of High-Quality Assets Supporting Premium Valuations: While baseline valuation multiples have held steady, buyers are paying premiums for clean, stable practices with an organic growth playbook due to a low supply of such assets.
Escalating Operational and Non-Clinical Complexity: Increasing staffing challenges, reimbursement pressures, rising operating costs, and growing administrative complexity are making partnerships with scaled dental organizations increasingly attractive to independent practice owners. For instance, wage inflation continues to persist and staff compensation in some cases has increased to levels greater than 25-30% of revenue.1
Continued investment in leading-edge technology is essential to remain competitive: Independent practices must fund implementations of AI-driven revenue cycle management, cloud-based practice management software, marketing strategy, and complex compliance frameworks to stay competitive.
Private Equity Capital Deployments and Recapitalization Timelines: Many active DSOs likely anticipate a formal recapitalization event within the next 12 to 36 months. To maximize their own enterprise value before hitting the market, these platforms must aggressively execute add-on acquisitions, creating a highly favorable environment for independent sellers.
Growing Seller Supply Could Shift Negotiating Leverage: Approximately 34% of active U.S. dentists are 55 or older, and the average retirement age has climbed to nearly 69 years.1 As this massive cohort inevitably brings their practices to market in volume over the next few years, the current low-supply dynamic will reverse, diluting seller leverage and potentially depressing multiples.
Media attention regarding corporate involvement in the practice of dentistry, particularly driven by private equity investments in independent practices, has shaped some legislative actions and influenced public opinion. The reality is that not all private equity owners are created equal and there are good and bad partners. Many general dental practices have successfully partnered with buyers to access the resources and infrastructure needed to scale, all while preserving clinical autonomy and independence.
The Corporate Practice of Dentistry, the dental profession’s equivalent of the Corporate Practice of Medicine, prohibits non-dentist business entities from owning or controlling dental practices in most U.S. states. Under a Dental Service Organization (DSO) structure, dentists retain ownership of the practice (i.e., clinical entity) and control over all clinical decisions and clinical-related matters. The DSO handles non-clinical functions including revenue cycle management, HR, marketing, procurement, and other admin tasks. The operational focus of DSOs is then on initiatives that drive growth without interfering with patient care.
While public sentiment is partially misunderstood, it is important for independent dental practices to conduct their own diligence on all prospective partners to fully understand how clinical governance would look following a transaction with a buyer.
The general dental sector continues through a defining consolidation phase characterized by a high-demand, low-supply operational environment. Private equity-backed DSO platforms are experiencing a massive push for liquidity, but it has been a tougher M&A environment for large platforms. As these major platforms extend their investment cycles, their mandate to execute add-on strategies continues while they wait to achieve a subsequent recapitalization event. This dynamic has helped maintain a strong market for high-performing, independent multi-site practices.
Consequently, this institutional pressure yields structural advantages for independent dental owners. Active M&A strategies between national DSOs, regional platforms, and DPOs are driving multiple arbitrage opportunities, compressed transaction timelines, and enhanced deal structures. PGP views 2026–2027 as a compelling transaction window, with strong buyer demand and constrained supply creating an attractive opportunity for founders to de-risk equity and select from a broad range of partnership alternatives.
No obligation. Completely confidential. Typically 30 minutes.
Sources & Citations
Physician Growth Partners · This content is provided for informational purposes only and does not constitute legal, financial, or investment advice. All transaction data sourced as cited. © 2026 Physician Growth Advisors, LLC. All rights reserved.